Healthcare Realty Trust Incorporated (NYSE:HR) Director Thomas N. Bohjalian Buys 7,750 Shares of Stock

Healthcare Realty Trust Incorporated (NYSE:HR) Director Thomas N. Bohjalian purchased 7,750 shares of the business’s stock in a transaction on Friday, November 22nd. The stock was acquired at an average cost of $17.39 per share, with a total value of $134,772.50. Following the completion of the acquisition, the director now directly owns 50,002 shares in the company, valued at $869,534.78. The trade was a 18.34 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Healthcare Realty Trust Stock Performance

Shares of NYSE:HR opened at $17.30 on Friday. Healthcare Realty Trust Incorporated has a twelve month low of $12.77 and a twelve month high of $18.90. The business has a fifty day moving average of $17.73 and a 200-day moving average of $17.25.

Healthcare Realty Trust Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, November 27th. Stockholders of record on Tuesday, November 12th will be paid a $0.31 dividend. The ex-dividend date of this dividend is Tuesday, November 12th. This represents a $1.24 dividend on an annualized basis and a dividend yield of 7.17%. Healthcare Realty Trust’s dividend payout ratio (DPR) is presently -78.48%.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on HR. Scotiabank boosted their price target on Healthcare Realty Trust from $17.00 to $18.00 and gave the company a “sector perform” rating in a research note on Wednesday, August 7th. Wells Fargo & Company reissued an “underweight” rating and issued a $17.00 price target (up previously from $16.00) on shares of Healthcare Realty Trust in a research note on Tuesday, October 1st. Finally, Wedbush boosted their price target on Healthcare Realty Trust from $15.00 to $18.00 and gave the company a “neutral” rating in a research note on Monday, August 5th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $17.17.

Institutional Trading of Healthcare Realty Trust

A number of hedge funds and other institutional investors have recently made changes to their positions in HR. Allspring Global Investments Holdings LLC increased its stake in shares of Healthcare Realty Trust by 38.1% in the second quarter. Allspring Global Investments Holdings LLC now owns 2,276 shares of the real estate investment trust’s stock valued at $38,000 after buying an additional 628 shares in the last quarter. EverSource Wealth Advisors LLC boosted its holdings in Healthcare Realty Trust by 260.6% in the second quarter. EverSource Wealth Advisors LLC now owns 2,809 shares of the real estate investment trust’s stock valued at $50,000 after acquiring an additional 2,030 shares during the last quarter. Point72 Hong Kong Ltd bought a new position in Healthcare Realty Trust in the third quarter valued at about $65,000. Harbor Capital Advisors Inc. bought a new position in Healthcare Realty Trust in the third quarter valued at about $89,000. Finally, GAMMA Investing LLC boosted its holdings in Healthcare Realty Trust by 67.2% in the second quarter. GAMMA Investing LLC now owns 5,569 shares of the real estate investment trust’s stock valued at $92,000 after acquiring an additional 2,238 shares during the last quarter.

About Healthcare Realty Trust

Healthcare Realty (NYSE: HR) is a real estate investment trust (REIT) that owns and operates medical outpatient buildings primarily located around market-leading hospital campuses. The Company selectively grows its portfolio through property acquisition and development. As the first and largest REIT to specialize in medical outpatient buildings, Healthcare Realty's portfolio includes more than 700 properties totaling over 40 million square feet concentrated in 15 growth markets.